Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Bloom Health Partners sees strong revenue of $9.8M in 2021 fiscal year driven by its operational health platform

The occupational health provider also delivered Adjusted EBITDA of nearly $2.4 million for the fiscal year ended September 30, 2021

Bloom Health Partners Inc (CSE:BLMH, OTCQB:BLMHF), the occupational health provider, has released its 2021 fiscal results showing strong revenue in its first full year as a company.

The Vancouver-based firm delivered $9.8 million in revenue and Adjusted EBITDA of nearly $2.4 million for the fiscal year ended September 30, 2021.

During the year, Bloom Health completed a reverse takeover of Round Hill Health Partners LLC to list on the Canadian Securities Exchange.

In the first half of 2021, prior to the acquisition, Round Hill Health Partners saw US$11,888,654 in revenue with US$5,507,998 of net income in the first six calendar months of 2021, according to Bloom.

READ: Bloom Health Partners says it has been awarded a statewide contract for coronavirus (COVID-19) testing for K-12 schools in Texas

"We're thrilled with the results of our first full fiscal year," said Andrew Morton, CEO of Bloom, in a statement. "As an Operational Health provider, we've set the stage to deliver successful Occupational Health Programs on our digital platform. Our business with film/TV productions, Fortune 500 companies and state school systems is providing a path to further expanding services and client base in 2022 and beyond.”

Morton told shareholders that the company is continuing its growth in 2022, with two recently announced state school contracts in Texas and Alabama, which are part of a US government US$10 billion school testing program.

“We continue to advance discussions with other large organizations and look forward to updating the market as this progresses,” Morton added. “Bloom has a strong management team and proven operations that are the foundation for growth by providing innovation in health and health-tech for large organizations."

The company ended its 2021 fiscal year with $5.6 million in cash.

Contact Angela at angela@proactiveinvestors.com

Follow her on Twitter @AHarmantas

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK